The global CAR T-cell therapy market, valued at USD 2.50 billion in 2024, is projected to grow at a CAGR of 15.20% during 2025–2034, reaching USD 10.29 billion by 2034, driven by rising cancer prevalence, advancements in immunotherapy, and expanding applications of personalized cell-based treatments. https://www.expertmarketresearch.com/reports/car-t-cell-therapy-market